A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 38/48 (2006.01)
Patent
CA 2119562
The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin A) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Method and compositions for the treatment of cerebral palsy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for the treatment of cerebral palsy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for the treatment of cerebral palsy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868115